Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
6.66
-0.17 (-2.49%)
Sep 11, 2026, 3:04 PM CST

SHE:300253 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,2612,1062,7823,1633,0932,750
Revenue Growth
-5.68%-24.30%-12.05%2.28%12.46%21.34%
Gross Profit
720.69691.431,1591,4231,3511,275
Operating Income
-355.51-224.19270.25395.7669.54279.34
Net Income
-432.31-373.8887.89357.96108.64378.17
Earnings Per Share
-0.20-0.170.040.160.050.18
EPS Growth
---75.05%221.70%-71.21%-23.34%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medical and Health Information Industry
1,9272,4452,8492,5282,311
Internet Medical and Health Industry
178.75336.81312.35563.07438.6
Unallocated Other
0.010.442.471.380.37
Total
2,1062,7823,1633,0932,750

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,5931,7621,3391,1141,2821,601
Total Debt
1,1651,1501,1311,0981,036936.48
Net Cash (Debt)
427.82611.59207.8315.99245.18664.07
Net Cash Growth
94.35%194.27%1199.84%-93.48%-63.08%-18.20%
Net Cash Per Share
0.190.280.100.010.110.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
516.66555.37407.53184.8100.44368.06
Capital Expenditures
-177.7-220.35-305.82-313.33-323.7-286.23
Free Cash Flow
338.96335.01101.71-128.53-223.2681.83
Free Cash Flow Growth
22.05%229.38%----59.76%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
31.87%32.83%41.65%44.97%43.69%46.35%
Operating Margin
-15.72%-10.64%9.71%12.51%2.25%10.16%
Pretax Margin
-22.46%-21.01%3.13%10.77%1.25%13.57%
Profit Margin
-19.12%-17.75%3.16%11.32%3.51%13.75%
FCF Margin
14.99%15.91%3.66%-4.06%-7.22%2.97%

Dividends

Fiscal YearFY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0150.0200.0100.020
Dividend Per Share Growth
-25.00%100.00%-50.00%-20.00%
Dividend Yield
0.21%0.28%0.10%0.12%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
--176.9542.85201.8895.11
Forward PE
249.7244.1925.5434.44171.3346.38
P/FCF Ratio
43.2557.93152.91--439.53
PS Ratio
6.489.225.594.857.0913.08